These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18097655)

  • 1. Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine.
    Schlagenhauf F; Juckel G; Koslowski M; Kahnt T; Knutson B; Dembler T; Kienast T; Gallinat J; Wrase J; Heinz A
    Psychopharmacology (Berl); 2008 Mar; 196(4):673-84. PubMed ID: 18097655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics.
    Juckel G; Schlagenhauf F; Koslowski M; Filonov D; Wüstenberg T; Villringer A; Knutson B; Kienast T; Gallinat J; Wrase J; Heinz A
    Psychopharmacology (Berl); 2006 Aug; 187(2):222-8. PubMed ID: 16721614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of antipsychotic treatment on brain reward system reactivity in schizophrenia patients.
    Kirsch P; Ronshausen S; Mier D; Gallhofer B
    Pharmacopsychiatry; 2007 Sep; 40(5):196-8. PubMed ID: 17874350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunction of ventral striatal reward prediction in schizophrenia.
    Juckel G; Schlagenhauf F; Koslowski M; Wüstenberg T; Villringer A; Knutson B; Wrase J; Heinz A
    Neuroimage; 2006 Jan; 29(2):409-16. PubMed ID: 16139525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia.
    Walter H; Kammerer H; Frasch K; Spitzer M; Abler B
    Psychopharmacology (Berl); 2009 Sep; 206(1):121-32. PubMed ID: 19521678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the reward system by antipsychotic treatment.
    Juckel G
    Dialogues Clin Neurosci; 2016 Mar; 18(1):109-14. PubMed ID: 27069385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do neuroleptics impair learning in schizophrenic patients?
    Cutmore TR; Beninger RJ
    Schizophr Res; 1990; 3(3):173-86. PubMed ID: 1980612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alterations of gait parameters under external cueing in schizophrenic patients: a switch study].
    Putzhammer A; Perfahl M; Pfeiff L; Broll K; Hess L; Ibach B
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S164-6. PubMed ID: 15570541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint.
    Bernardo M; Parellada E; Lomeña F; Catafau AM; Font M; Gómez JC; López-Carrero C; Gutiérrez F; Pavía J; Salamero M
    Psychiatry Res; 2001 Aug; 107(2):87-97. PubMed ID: 11530275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implicit and explicit learning in schizophrenics treated with olanzapine and with classic neuroleptics.
    Stevens A; Schwarz J; Schwarz B; Ruf I; Kolter T; Czekalla J
    Psychopharmacology (Berl); 2002 Mar; 160(3):299-306. PubMed ID: 11889499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prepulse inhibition of acoustic startle in subjects with schizophrenia treated with olanzapine or haloperidol.
    Duncan E; Szilagyi S; Schwartz M; Kunzova A; Negi S; Efferen T; Peselow E; Chakravorty S; Stephanides M; Harmon J; Bugarski-Kirola D; Gonzenbach S; Rotrosen J
    Psychiatry Res; 2003 Aug; 120(1):1-12. PubMed ID: 14500109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human reward system activation is modulated by a single dose of olanzapine in healthy subjects in an event-related, double-blind, placebo-controlled fMRI study.
    Abler B; Erk S; Walter H
    Psychopharmacology (Berl); 2007 Apr; 191(3):823-33. PubMed ID: 17265148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cognition, schizophrenia and the effect of antipsychotics].
    Stip E
    Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D2 receptor occupancy in schizophrenia.
    Paquet F; Soucy JP; Stip E; Lévesque M; Elie A; Bédard MA
    J Neuropsychiatry Clin Neurosci; 2004; 16(1):47-56. PubMed ID: 14990759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis.
    Zipursky RB; Christensen BK; Daskalakis Z; Epstein I; Roy P; Furimsky I; Sanger T; Kapur S
    Can J Psychiatry; 2005 Jul; 50(8):462-9. PubMed ID: 16127964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine.
    Allan ER; Sison CE; Alpert M; Connolly B; Crichton J
    Psychopharmacol Bull; 1998; 34(1):71-4. PubMed ID: 9564201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching schizophrenia patients from typical neuroleptics to olanzapine: effects on BOLD response during attention and working memory.
    Schlagenhauf F; Wüstenberg T; Schmack K; Dinges M; Wrase J; Koslowski M; Kienast T; Bauer M; Gallinat J; Juckel G; Heinz A
    Eur Neuropsychopharmacol; 2008 Aug; 18(8):589-99. PubMed ID: 18554874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
    Markianos M; Hatzimanolis J; Lykouras L
    Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol.
    Tauscher J; Küfferle B; Asenbaum S; Fischer P; Pezawas L; Barnas C; Tauscher-Wisniewski S; Brücke T; Kasper S
    Psychopharmacology (Berl); 1999 Jan; 141(2):175-81. PubMed ID: 9952042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior haloperidol, but not olanzapine, exposure augments the pursuit of reward cues: implications for substance abuse in schizophrenia.
    Bédard AM; Maheux J; Lévesque D; Samaha AN
    Schizophr Bull; 2013 May; 39(3):692-702. PubMed ID: 22927669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.